Rheumatoid arthritis (RA) is partly heritable; genetic and serological markers are known to confer risk of developing pathology. But given clinical heterogeneity in RA, can we predict who will develop severe disease? Substantial heritability of erosive progression rates has now been identified, but better prognostic biomarkers remain wanting.
References
Knevel, R. et al. Genetic predisposition of the severity of joint destruction in rheumatoid arthritis: a population-based study. Ann. Rheum. Dis. 71, 707–709 (2012).
van Gaalen, F. A. et al. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis. Arthritis Rheum. 50, 2113–2121 (2004).
Lindqvist, E., Eberhardt, K., Bendtzen, K., Heinegard, D. & Saxne, T. Prognostic laboratory markers of joint damage in rheumatoid arthritis. Ann. Rheum. Dis. 64, 196–201 (2005).
Smolen, J. S. et al. The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now? Arthritis Res. Ther. 10, 208 (2008).
Lawrence, J. S. & Ball, J. Genetic studies on rheumatoid arthritis. Ann. Rheum. Dis. 17, 160–168 (1958).
Marinou, I., Maxwell, J. R. & Wilson, A. G. Genetic influences modulating the radiological severity of rheumatoid arthritis. Ann. Rheum. Dis. 69, 476–482 (2010).
van der Helm-van Mil, A. H., Kern, M., Gregersen, P. K. & Huizinga, T. W. Variation in radiologic joint destruction in rheumatoid arthritis differs between monozygotic and dizygotic twins and pairs of unrelated patients. Arthritis Rheum. 54, 2028–2030 (2006).
deCODE genetics [online] (2010).
Visscher, P. M. et al. Assumption-free estimation of heritability from genome-wide identity-by-descent sharing between full siblings. PLoS Genet. 2, e41 (2006).
MacGregor, A. J. et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum. 43, 30–37 (2000).
Acknowledgements
The work of S. Raychaudhuri is supported by funds from the NIH (K08AR055688), Arthritis Foundation, the Harvard University Milton Fund, and Brigham and Women's Hospital. E. A. Stahl's work is supported by NIH grant U01GM092691 to Robert M. Plenge, MD PhD (Brigham and Women's Hospital, Harvard Medical School).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Stahl, E., Raychaudhuri, S. Evidence for a genetic component to disease severity in RA. Nat Rev Rheumatol 8, 312–313 (2012). https://doi.org/10.1038/nrrheum.2012.74
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2012.74
- Springer Nature Limited